ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round

Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv.ImmunOs Therapeutics AG, a…

This content is for members only.
Login to Read More Join Now

PrintFriendly

FLX Networks’ $10 Million Growth Equity Financing Round

Trive Capital’s Investment in Forward Slope

Fortune Brands’ US$800 Million Transaction with ASSA ABLOY

Corteva Agriscience’s $1.2 Billion Acquisition of Stoller Group

Caldic’s Acquisition of CAIF

Metabase’s Acquisition of HumanApis

Michelmersh Brick Holdings Plc’s Acquisition of FabSpeed Holdings Ltd

BorgWarner’s Acquisition of Drivetek AG

Rainbow Agro’s Acquisition of Exclusivas Sarabia

MTN Nigeria Communications PIc’s €100 Million Financing Round

Akdital’s Initial Public Offering

Egypt’s Contract for the Operation and Maintenance First High-Speed Rail Network

Aura Investments’ Bonds Private Placement

Maadaney Gourmet’s Dispute Against Motion to Certify Class Action

Debiopharm Innovation Fund’s Series Seed Financing Round

ArcelorMittal Nippon Steel India Limited’s Acquisition of Ports and Power Assets from Essar

Huzhou Moganshan High-tech Group’s Bonds Offering

Syngenta Group’s Syndicated Loan Financing

Uruguay Will Levy Corporate Income Tax on Foreign-Sourced Income

Baker Botts Welcomes Litigation Partner in Dallas

McDermott Adds Former Assistant US Attorney in Chicago

Reduction of share capital to partially cover losses of more than a third, a new perspective?

IMU (Municipal Property Tax) on first house: double exemption to spouses living in two different municipalities

Uruguay – Sustainable Bond Framework

Baker Botts Welcomes Litigation Partner in Dallas

McDermott Adds Former Assistant US Attorney in Chicago

Lawson Lundell Welcomes New Counsel Cecilia Barnes

ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round

Author: Federica Tiefenthaler